Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 105,676	$ 183,426
Investment securities available for sale	484,416	444,703
Loans held for sale	0	2,301
Loans, less allowance for credit losses of $12,330 at March 31, 2023 and $10,717 at December 31, 2022	906,022	903,968
Other real estate owned	83	0
Premises and equipment, net	18,730	18,100
Bank owned life insurance	15,797	16,020
Goodwill	5,502	5,502
Accrued interest receivable and other assets	42,256	47,024
Total assets	1,578,482	1,621,044
Deposits:
Non-interest bearing	741,754	766,549
Interest bearing	664,991	691,260
Total deposits	1,406,745	1,457,809
Repurchase agreements	16,914	18,624
Accrued interest payable and other liabilities	16,000	15,297
Other borrowings	10,000	0
Junior subordinated deferrable interest debentures	0	10,310
Total liabilities	1,449,659	1,502,040
Commitments and contingencies (Note 5)
Shareholders’ equity:
Common stock, no par value; 22,500,000 shares authorized; issued and outstanding – 5,862,148 shares at March 31, 2023 and 5,850,216 at December 31, 2022	27,608	27,372
Retained earnings	133,997	128,388
Accumulated other comprehensive loss, net	(32,782)	(36,756)
Total shareholders’ equity	128,823	119,004
Total liabilities and shareholders’ equity	$ 1,578,482	$ 1,621,044